It should be noted that this patient fulfilled the Amsterdam II criteria, and other individuals in the family with the same pathogenic germline MSH2 variant displayed loss of MSH2 and MSH6 upon IHC on their tumor tissue indicating that this variant does lead to protein loss in LS-associated tumors. This evidence concerns the gene MSH6 and neoplasm.